Kwang Dong Pharmaceutical Co., Ltd. (009290) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kwang Dong Pharmaceutical Co., Ltd. (009290:KRX), powered by AI.

Current Price
₩6,210
P/E Ratio
14.7
Market Cap
309.3B
Sector
Consumer Defensive
What is the Kwang Dong Pharmaceutical Co., Ltd. stock price forecast?

Kwang Dong Pharmaceutical Co., Ltd. is currently trading at ₩6,210. View real-time AI analysis on Alpha Lenz.

What is Kwang Dong Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Kwang Dong Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Kwang Dong Pharmaceutical Co., Ltd.'s P/E ratio?

Kwang Dong Pharmaceutical Co., Ltd.'s P/E ratio is 14.7.

Kwang Dong Pharmaceutical Co., Ltd.

KRX · 009290
₩6,210-80(-1.27%)Market closedKRX regular session 09:00–15:30 KST
Ask about Kwang Dong Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Kwang Dong Pharmaceutical Co., Ltd. trades at a P/E of 14.7 (undervalued) with modest ROE of 3.4%.

Ask for details

Company Overview

Kwang Dong Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, known for its extensive portfolio of health products and medicinal solutions. The company's primary function is to research, develop, and produce a wide array of pharmaceuticals, including prescription medications and over-the-counter remedies. Founded with a commitment to enhancing public health, Kwang Dong has made significant strides in areas such as herbal medicine and functional foods, reflecting its roots in traditional Korean medicinal practices. Kwang Dong Pharmaceutical has successfully integrated modern technology with traditional techniques, thereby creating a diverse range of products that cater to varying health needs. This includes health drinks and tonics, which are particularly popular in the Asian markets. Its impact is notable across sectors like healthcare and wellness, reflecting its dedication to promoting wellbeing through scientifically-backed natural health solutions. In the financial market, Kwang Dong Pharmaceutical is recognized for its steady contribution to the pharmaceutical sector, embodying resilience through innovation. Its role underscores a critical intersection between traditional medicinal approaches and contemporary pharmaceutical advancements, maintaining a significant market presence and aligning health solutions with consumer needs.

CEO최성원
SectorConsumer Defensive
IndustryPackaged Foods
Employees1,030

Company Statistics

FY 2025

Profile

₩309,256,807,680Market Cap
₩1,659,512,457,700Revenue
49.80MShares Out
1,030Employees

Margins

18.15%Gross
2.61%EBITDA
1.87%Operating
1.87%Pre-Tax
1.29%Net

Valuation

14.75P/E
0.47P/B
0.19EV/Sales
12.19EV/EBITDA
5.53P/FCF

Growth (CAGR)

5.05%Rev 3Yr
5.94%Rev 5Yr
-6.71%Op Inc 3Yr
-7.80%Op Inc 5Yr
-7.21%Net Inc 3Yr
-14.10%Net Inc 5Yr

Returns

1.71%ROA
3.40%ROE
3.37%ROIC

Financial Health

₩140,991,116,870Cash & Cash Equivalents
₩467,541,991,590Net Debt
85.49%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Kwang Dong Pharmaceutical Co., Ltd. (ticker: 009290) is a company listed on KRX in the Consumer Defensive sector (Packaged Foods). It has approximately 1,030 employees. Market cap is $309.3B.

The current price is ₩6,210 with a P/E ratio of 14.75x and P/B of 0.47x.

ROE is 3.40% and operating margin is 1.87%. Annual revenue is $1.7T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Kwang Dong Pharmaceutical Co., Ltd. (009290) Stock Forecast 2026 ₩6,210 — Price, Financials & Analyst Targets | Alpha Lenz